InsiderClue
Insiders · Profile

Sofinnova Venture Partners IX, L.P.

10% owner at NextCure · 10% owner at aTYR PHARMA. Filing since 12 May 2015. CIK 0001612133

NXTC NextCure, Inc. 10% owner · 2 trades ATYR aTYR PHARMA INC 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
NXTC NextCure, Inc.
15 Nov 2019
10% owner
Bought
150,000
$5.51M
5.9%
NXTC NextCure, Inc.
13 May 2019
10% owner
Bought
400,000
$6.00M
18.9%
ATYR aTYR PHARMA INC
12 May 2015
10% owner
Bought
320,000
$4.48M
20.7%
3 decisions on file.